Literature DB >> 29518066

Notes from the Field: Brucella abortus Vaccine Strain RB51 Infection and Exposures Associated with Raw Milk Consumption - Wise County, Texas, 2017.

Caitlin M Cossaboom, Grishma A Kharod, Johanna S Salzer, Rebekah V Tiller, Lindsay P Campbell, Karen Wu, María E Negrón, Naomi Ayala, Nicole Evert, Jill Radowicz, Jennifer Shuford, Shelley Stonecipher.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29518066      PMCID: PMC5844281          DOI: 10.15585/mmwr.mm6709a4

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


× No keyword cloud information.
In July 2017, the Texas Department of State Health Services (DSHS) Region 2/3 office reported a human case of brucellosis associated with the consumption of raw (unpasteurized) cow’s milk purchased from a dairy in Paradise, Texas. CDC’s Bacterial Special Pathogens Branch (BSPB) confirmed the isolate as Brucella abortus vaccine strain RB51 (RB51). Brucellosis is a zoonotic bacterial disease that affects humans and many animal species. In humans, the disease is characterized by fever and nonspecific influenza-like symptoms that frequently include myalgia, arthralgia, and night sweats. Without appropriate treatment, brucellosis can become chronic, and life-threatening complications can arise. Human brucellosis transmitted by cattle was once common in the United States. Control strategies have focused on elimination of brucellosis through vaccination and surveillance of cattle herds, in addition to milk pasteurization. Because of these measures, domestically acquired human cases are now rare (). RB51, a live-attenuated vaccine used to prevent B. abortus infection in cattle, has been documented to cause human disease, most commonly through occupational exposures such as needle sticks (). Importantly, unlike wild strains of B. abortus, RB51 does not stimulate an antibody response detectable by routine serological assays, requiring culture for confirmation. Additionally, RB51 is resistant to rifampin, a common treatment choice for human brucellosis (,). This case represents the first documented instance of human brucellosis caused by RB51 through consumption of raw milk acquired in the United States. Following isolation of RB51 from the patient’s blood, bulk milk tank samples from the farm tested positive for RB51 by polymerase chain reaction and bacterial culture. Culture of individual milk samples from all 43 cows in the herd identified two RB51 culture-positive cows. Subsequent whole genome sequencing indicated genetic relatedness between the cow and human isolate. In Texas, farm sales of raw milk products to the public are legal with a “Grade ‘A’ Raw for Retail” license, regulated by the DSHS Milk and Dairy Group. By the end of August, through correspondence with the dairy, DSHS had identified approximately 800 persons who might have visited the farm during June 1–August 7. On September 1, Texas DSHS and BSPB began notification calls to these households, recommending that all exposed persons (i.e., those who consumed raw milk products from the farm during June 1–August 7) seek medical attention and begin 3 weeks of postexposure prophylaxis, even if asymptomatic (). Contact information was available for 582 households. The notification was issued successfully to 397 (68.2%) households. Among these notified households, 324 (81.6%) identified at least one exposed household member. Contacted persons referred 34 additional potentially exposed households, including households from seven other states.* A nationwide press release and Health Alert Network Health Advisory were issued in September to facilitate further identification of exposed persons (). To date, there are no other confirmed cases associated with this investigation. CDC and Texas DSHS continue measures to increase awareness among health care providers and the public regarding unique challenges associated with treatment and diagnosis of RB51 in humans and the risks of consuming raw milk.
  2 in total

1.  The Animal and Plant Health Inspection Service (APHIS) brucellosis eradication program in the United States.

Authors:  Valerie E Ragan
Journal:  Vet Microbiol       Date:  2002-12-20       Impact factor: 3.293

2.  Biological properties of RB51; a stable rough strain of Brucella abortus.

Authors:  G G Schurig; R M Roop; T Bagchi; S Boyle; D Buhrman; N Sriranganathan
Journal:  Vet Microbiol       Date:  1991-07       Impact factor: 3.293

  2 in total
  15 in total

1.  Serological detection of brucellosis among febrile, malaria-negative children and domesticated dogs in an urban African setting.

Authors:  John B Kalule; Joseph Tomusange; Teddy Namatovu
Journal:  Afr J Lab Med       Date:  2020-09-30

2.  Seroepidemiology of bovine brucellosis in Colombia's preeminent dairy region, and its potential public health impact.

Authors:  Olga Lucia Herrán Ramirez; Huarrisson Azevedo Santos; Ingrid Lorena Jaramillo Delgado; Isabele da Costa Angelo
Journal:  Braz J Microbiol       Date:  2020-09-12       Impact factor: 2.476

3.  Intratracheal Inoculation with Brucella melitensis in the Pregnant Guinea Pig Is an Improved Model for Reproductive Pathogenesis and Vaccine Studies.

Authors:  Martha E Hensel; Sankar P Chaki; Lauren Stranahan; Anthony E Gregory; Erin J van Schaik; Daniel G Garcia-Gonzalez; Omar Khalaf; James E Samuel; Angela M Arenas-Gamboa
Journal:  Infect Immun       Date:  2020-09-18       Impact factor: 3.441

4.  Notes from the Field: Adverse Event Associated with Unintentional Exposure to the Brucella abortus RB51 Vaccine - Oregon, December 2017.

Authors:  Sarah M Hatcher; David Shih; Jacobey Holderman; Caitlin Cossaboom; Richard Leman; Emilio DeBess
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-07-06       Impact factor: 17.586

5.  Environmental distribution of certain modified live-virus vaccines with a high safety profile presents a low-risk, high-reward to control zoonotic diseases.

Authors:  Jennifer R Head; Ad Vos; Jesse Blanton; Thomas Müller; Richard Chipman; Emily G Pieracci; Julie Cleaton; Ryan Wallace
Journal:  Sci Rep       Date:  2019-05-01       Impact factor: 4.379

6.  Proteomic Analysis of Membrane Blebs of Brucella abortus 2308 and RB51 and Their Evaluation as an Acellular Vaccine.

Authors:  Minerva Araiza-Villanueva; Eric Daniel Avila-Calderón; Leopoldo Flores-Romo; Juana Calderón-Amador; Nammalwar Sriranganathan; Hamzeh Al Qublan; Sharon Witonsky; Ma Guadalupe Aguilera-Arreola; María Del Socorro Ruiz-Palma; Enrico A Ruiz; Francisco Suárez-Güemes; Zulema Gómez-Lunar; Araceli Contreras-Rodríguez
Journal:  Front Microbiol       Date:  2019-11-29       Impact factor: 5.640

7.  Different Impacts of MucR Binding to the babR and virB Promoters on Gene Expression in Brucella abortus 2308.

Authors:  Giorgia Borriello; Veronica Russo; Rubina Paradiso; Marita Georgia Riccardi; Daniela Criscuolo; Gaetano Verde; Rosangela Marasco; Paolo Vincenzo Pedone; Giorgio Galiero; Ilaria Baglivo
Journal:  Biomolecules       Date:  2020-05-19

8.  Vaccine Candidate Brucella melitensis 16MΔvjbR Is Safe in a Pregnant Sheep Model and Confers Protection.

Authors:  Martha E Hensel; Daniel G Garcia-Gonzalez; Sankar P Chaki; Airn Hartwig; Paul W Gordy; Richard Bowen; Thomas A Ficht; Angela M Arenas-Gamboa
Journal:  mSphere       Date:  2020-05-13       Impact factor: 4.389

Review 9.  Bovine brucellosis - a comprehensive review.

Authors:  Sandip Kumar Khurana; Anju Sehrawat; Ruchi Tiwari; Minakshi Prasad; Baldev Gulati; Muhammad Zubair Shabbir; Rajesh Chhabra; Kumaragurubaran Karthik; Shailesh Kumar Patel; Mamta Pathak; Mohd Iqbal Yatoo; Vivek Kumar Gupta; Kuldeep Dhama; Ranjit Sah; Wanpen Chaicumpa
Journal:  Vet Q       Date:  2021-01-01       Impact factor: 3.320

10.  Building the Evidence Base for the Prevention of Raw Milk-Acquired Brucellosis: A Systematic Review.

Authors:  Shakirat A Adetunji; Gilbert Ramirez; Allison R Ficht; Ligia Perez; Margaret J Foster; Angela M Arenas-Gamboa
Journal:  Front Public Health       Date:  2020-03-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.